Iaso Therapeutics to Showcase Novel mQβ Vaccine Platform at 2026 World Vaccine Congress

2026-02-17T12:10:59-05:00

Iaso Therapeutics will present at the 2026 World Vaccine Congress on Tuesday, March 31. President and CEO Robert Forgey, MS, MBA, will provide an overview of Iaso’s technology and commercial strategy during his live presentation at the Innovator Showcase.